The voice of utah’s life sciences community

Medical Device

Pharmaceuticals

Diagnostics / Laboratory

Biotechnology

BioUtah is the common voice and flag bearer for Utah’s life sciences industry comprised of medical devices, pharmaceutical, diagnostics, laboratories, research facilities and biotechnology of all types. BioUtah connects industry with government, academia, capital markets, media and service providers. Together we form an ecosystem that fosters collaboration, promotes innovation and delivers technology that saves lives.

Learn More

Icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY

BIO Business Solutions

Savings achieved through this program on lab supplies, equipment, shipping and much more, often exceed the annual cost membership in BioUtah.

Biosphere 2025 Available

From Utah's isotopia to local neurotech and much more, check out the latest issue.

Featured New Member

Ardelyx® is dedicated to improving patients' lives by discovering, developing, and commercializing first-in-class medicines

Utah Life Sciences by the Numbers

Kem C. Gardner Report Findings Nov. 2023

Utah is #3 in the nation for life sciences growth.

Life sciences is a $21.6 billion industry in Utah.

Source: Pace, L. and Brandley, A. (2023), Economic Impacts of Utah’s Life Sciences and Health Care Innovation Industry: Utah’s Life Sciences and Health Care Innovation Industry Creates Substantial Economic Impacts Across the State, Kem C. Gardner Policy Institute, University of Utah.

BioUtah News

February 5, 2026

Sen. Mike Lee’s Deputy Chief Tours Sorenson Center for Medical Innovation

Senator Lee’s Deputy chief of staff Justin Anthony yesterday toured the new James LeVoy Sorenson Center for Medical Innovation (SCMI) at the University of Utah. The four-story, nearly 60,000-square-foot facility, led by Executive Director, Mark Paul, features advanced prototyping labs, a clinical bio-tissue surgery suite, and incubator spaces designed to foster, develop, and commercialize next-generation […]

February 5, 2026

Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay

February 5, 2026

Owlet® Announces Strategic AI Partnership with webAI to Power the Next Generation of Personalized Infant Health and Sleep Insights

Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data.

January 29, 2026

Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies

January 29, 2026

Behavioral Health Assessment Using Vocal Biomarkers

January 28, 2026

Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West

January 22, 2026

Owlet’s First Baby Sleep Report Analyzes Data from Over 1.2 Million Owlet Monitored Babies

Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep – evaluating bedtimes, wake-ups, sleep stretches, and biometric trends

January 22, 2026

PhotoPharmics Announces Publication of Phase 2 Clinical Trial Results in Neurotherapeutics and Its Role in the Company’s Phase 3/Pivotal Clinical Trial

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease

More BioUtah News